ARCHEMIX
Archemix Corp., a biotechnology company, engages in discovering, developing, and commercializing aptamer therapeutics for the prevention and treatment of chronic and acute diseases in Massachusetts. Its aptamer product candidates include ARC1779 for thrombotic microangiopathyies and carotid endarterectomy surgical procedure. The company also offers product candidates for cardiovascular, hematology, and oncology diseases. Archemix Corp. was incorporated in 2000 and is based in Cambridge, Massachusetts.
ARCHEMIX
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2000-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.archemix.com
Total Employee:
51+
Status:
Closed
Contact:
(415) 367-9400
Email Addresses:
[email protected]
Total Funding:
101.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Apache PHP Amazon Route 53 GlobalSign WordPress 5.4 DreamHost Hosting
Founder
Investors List
Prospect Venture Partners
Prospect Venture Partners investment in Series B - Archemix
POSCO BioVentures
POSCO BioVentures investment in Series B - Archemix
Atlas Venture
Atlas Venture investment in Series B - Archemix
Care Capital
Care Capital investment in Series B - Archemix
MDS Capital
MDS Capital investment in Series B - Archemix
U.S. Trust
U.S. Trust investment in Series B - Archemix
Rho Ventures
Rho Ventures investment in Series B - Archemix
Schroder Ventures
Schroder Ventures investment in Series B - Archemix
Highland Capital Partners
Highland Capital Partners investment in Series B - Archemix
Care Capital
Care Capital investment in Series A - Archemix
